Abstract:Abstract BackgroundBreast cancer (BC) patients were threatened by distant metastasis and drug resistance for a long time. The mechanism was to be explored urgently. Proteasome 26S subunit non-ATPase 8 (PSMD8) was associated with protein degradation, but little was known about its role in BC.MethodsThe bioinformatics analysis was obtained from public databases. Breast cancer cell lines were knocked down or overexpressed PSMD8/kinesin family member 10 (KIF10) and detected their ability of proliferation and invasion. epithelial-to-mesenchymal transition (EMT)-related markers were detected by the western blot and immunohistochemistry. In vivo models were established to verify the effect of PSMD8 on tumor growth and distant metastasis. Cells were exposed to paclitaxel (PTX) and examined their apoptosis by flow cytometry.ResultsIn the present study, we defined PSMD8 as a tumor-promoting molecule. PSMD8 was abnormally upregulated in BC tissues compared with adjacent tissues. High PSMD8 expression was related to poor prognosis in BC patients. The knockdown of PSMD8 attenuated the biological effect and epithelial-mesenchymal transition (EMT) progression in vitro and in vivo, and the overexpression of PSMD8 increased tumor progression in vitro. Furthermore, PSMD8 knockdown dramatically augmented the sensitivity of BC cells to paclitaxel, whereas PSMD8 overexpression showed the opposite effects. Mechanistic analysis indicated that PSMD8 activated the expression of kinesin family member 10 (KIF10) and its downstream extracellular regulated MAP kinase (ERK) signaling. Similar to PSMD8, we revealed that the expression of KIF10, which showed a positive correlation with PSMD8, was increased in BC tissues compared with adjacent tissues and associated with a poor prognosis of BC patients. The KIF10 knockdown significantly antagonized the facilitating effect of PSMD8 on the EMT program and chemotherapy tolerance. Finally, knocking down the level of KIF10 or inhibiting the ERK pathway in PSMD8-overexpressing cell lines partially blocked EMT progression and resistance against paclitaxel (PTX). ConclusionsIn conclusion, our results demonstrated that the PSMD8/KIF10 axis promoted BC development and PTX resistance via the ERK pathway. Our findings provide a theoretical basis for targeting PSMD8 to BC cells as a novel target for the treatment of BC.

PDSS2 Promotes Epithelial-Mesenchymal Transition and Angiogenesis in Breast Cancer Cells by Activating the NF-KB Pathway

Increased Expression of Preprotachykinin-I and Neurokinin Receptors in Human Breast Cancer Cells: Implications for Bone Marrow Metastasis.

PD-L1-expressing B cells promote murine breast cancer development and mediate response to anti-PD-L1 immune checkpoint inhibitor.

SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer

DPM2 serve as novel oncogene and prognostic marker transactivated by ESR1 in breast cancer

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration

PDP1 promotes the progression of breast cancer through STAT3 pathway

PD-L1 intrinsically promotes the proliferation of breast cancer cells through the SKP2-p27/p21 axis

Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-kappa B signaling and c-Myc nuclear translocation in vitro

PCDHA1 High Expression is Associated With Poor Prognosis and Correlated With Immune Cell Infiltration in Breast Cancer

FZD2 promotes TGF-β-induced epithelial-to-mesenchymal transition in breast cancer via activating notch signaling pathway

MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer

Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.

Up-regulation of FN1, Activation of Maturation Promoting Factor and Associated Signaling Pathway Facilitates Epithelial-Mesenchymal Transition, Inhibits Apoptosis and Elevates Proliferation Rate of Breast Cancer Cells: In Silico Analysis of Microarray Datasets

PSMD8 Promotes Breast Cancer Progression and Attenuates Paclitaxel Sensitivity by Regulating the Expression of KIF10

NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1

Anticancer Activity of Pdss2, Prenyl Diphosphate Synthase, Subunit 2, in Gastric Cancer Tissue and the Sgc7901 Cell Line

NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer

PKM2 Promotes Stemness of Breast Cancer Cell by Through Wnt/β-catenin Pathway

EPAS1 promote tumor progression by interacting with Wnt/β-catenin signaling in pancreatic cancer

PD‐L1 regulates epithelial–mesenchymal transition and cancer stem cell phenotypes in Hepatocellular Carcinoma through SGK2/β‐catenin signaling pathway